These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 20650582)
1. [Measure of effectiveness and adherence to antiretroviral therapy in HIV-infected patients in Cameroon]. Mahy S; Duong M; Huraux JM; Aurenche C; Ndong JG; Birguel J; Piroth L; Chavanet P Med Mal Infect; 2011 Apr; 41(4):176-80. PubMed ID: 20650582 [TBL] [Abstract][Full Text] [Related]
2. Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the Stratall ANRS 12110/ESTHER trial in Cameroon. Boullé C; Kouanfack C; Laborde-Balen G; Aghokeng AF; Boyer S; Carrieri MP; Kazé S; Mben JM; Dontsop M; Spire B; Peeters M; Mpoudi-Ngolé E; Delaporte E; Laurent C; Clin Infect Dis; 2013 Aug; 57(4):604-7. PubMed ID: 23667264 [TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus in an aging population, a complication of success. Kirk JB; Goetz MB J Am Geriatr Soc; 2009 Nov; 57(11):2129-38. PubMed ID: 19793157 [TBL] [Abstract][Full Text] [Related]
4. The link between religion and HAART adherence in pediatric HIV patients. Park J; Nachman S AIDS Care; 2010 May; 22(5):556-61. PubMed ID: 20397076 [TBL] [Abstract][Full Text] [Related]
5. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)]. Panel de expertos de GESIDA y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714 [TBL] [Abstract][Full Text] [Related]
6. Criteria for initiating highly active antiretroviral therapy and short-term immune response among HIV-1-infected patients in Côte d'Ivoire. Diabaté S; Alary M HIV Med; 2009 Nov; 10(10):640-6. PubMed ID: 19659945 [TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy in public and private routine health care clinics in Cameroon: lessons from the Douala antiretroviral (DARVIR) initiative. Laurent C; Meilo H; Guiard-Schmid JB; Mapouré Y; Noël JM; M'Bangué M; Joko A; Rozenbaum W; Ntoné FN; Delaporte E Clin Infect Dis; 2005 Jul; 41(1):108-11. PubMed ID: 15937770 [TBL] [Abstract][Full Text] [Related]
8. Validation of the Special Projects of National Significance adherence tool in HIV/AIDS patients. Julian FS; Martin P; Erickson SR Ann Pharmacother; 2010 Jun; 44(6):1003-9. PubMed ID: 20442352 [TBL] [Abstract][Full Text] [Related]
9. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Sieleunou I; Souleymanou M; Schönenberger AM; Menten J; Boelaert M Trop Med Int Health; 2009 Jan; 14(1):36-43. PubMed ID: 19017309 [TBL] [Abstract][Full Text] [Related]
10. Adherence to highly active antiretroviral therapy. Zuger A AIDS Clin Care; 1997 Nov; 9(11):86-7. PubMed ID: 11364775 [TBL] [Abstract][Full Text] [Related]
12. Adherence to antiretroviral therapy in pediatric patients with human immunodeficiency virus (HIV-1). Burack G; Gaur S; Marone R; Petrova A J Pediatr Nurs; 2010 Dec; 25(6):500-4. PubMed ID: 21035017 [TBL] [Abstract][Full Text] [Related]
13. Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia. Pujades-Rodríguez M; Schramm B; Som L; Nerrienet E; Narom P; Chanchhaya N; Ferradini L; Balkan S Trop Med Int Health; 2011 Feb; 16(2):205-13. PubMed ID: 21087376 [TBL] [Abstract][Full Text] [Related]
14. Long-term trends in adherence to antiretroviral therapy from start of HAART. Cambiano V; Lampe FC; Rodger AJ; Smith CJ; Geretti AM; Lodwick RK; Puradiredja DI; Johnson M; Swaden L; Phillips AN AIDS; 2010 May; 24(8):1153-62. PubMed ID: 20299959 [TBL] [Abstract][Full Text] [Related]
15. [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy]. Jambroes M; Weverling GJ; Reiss P; Danner SA; Jurriaans S; ten Veen JH; van der Ende ME; Schutten M; Schneider MM; Schuurman R; Mulder JW; Kroes AC; Lange JM; de Wolf F; Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1591-7. PubMed ID: 11534377 [TBL] [Abstract][Full Text] [Related]
16. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms. Webb MS; Vanable PA; Carey MP; Blair DC AIDS Educ Prev; 2009 Jun; 21(3 Suppl):94-105. PubMed ID: 19537957 [TBL] [Abstract][Full Text] [Related]
17. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
18. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384 [TBL] [Abstract][Full Text] [Related]
20. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]